UCLA Med Ctr [clinicaltrials_resource:d704bf4060bf5db2d50cb0b00a1f8802]
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection [clinicaltrials:NCT00000959]An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC) [clinicaltrials:NCT00002255]A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related Complex [clinicaltrials:NCT00002281]
location [clinicaltrials_vocabulary:location]
UCLA Med Ctr [clinicaltrials_resource:d704bf4060bf5db2d50cb0b00a1f8802]
Bio2RDF identifier
d704bf4060bf5db2d50cb0b00a1f8802
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d704bf4060bf5db2d50cb0b00a1f8802
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:d704bf4060bf5db2d50cb0b00a1f8802
title
UCLA Med Ctr
@en
type
label
UCLA Med Ctr [clinicaltrials_resource:d704bf4060bf5db2d50cb0b00a1f8802]
@en